SCHEMBL7425271

SCHEMBL7425271

CCCc1[nH]c2cc(C(=O)O)ccc2c1C(=O)C1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.43
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 4/20 0.41
HSD17B10 Q99714 3/20 0.41
GAA P10253 2/20 0.41
HPGD P15428 2/20 0.41
RAB9A P51151 1/20 0.40
PPARG P37231 1/20 0.40
PSMD14 O00487 1/20 0.40
RECQL P46063 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KMT2A Q03164 3/20 0.38
MEN1 O00255 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CCR3 P51677 1/20 0.38
PARP1 P09874 1/20 0.38
CYP2C19 P33261 1/20 0.38
PDE4B Q07343 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7461131 0.99 KDM4E (0.41) SRD5A2KDM4EALDH1A1HSD17B10GAA
SCHEMBL7471184 0.96 KDM4E (0.41) SRD5A2KDM4EALDH1A1HSD17B10GAA
SCHEMBL7467711 0.94 KDM4E (0.43) KDM4EALDH1A1HSD17B10GAAHPGD
SCHEMBL7417074 0.90 CHEK2 (0.47) KDM4EALDH1A1HSD17B10GAAKMT2A
SCHEMBL7422886 0.88 CHEK2 (0.46) KDM4EALDH1A1HSD17B10GAAKMT2A
SCHEMBL7421012 0.88 KMT2A (0.54) KDM4EALDH1A1HSD17B10GAAHPGD
SCHEMBL7477858 0.86 KMT2A (0.55) KDM4EALDH1A1HSD17B10GAAHPGD
SCHEMBL7467838 0.86 CHEK2 (0.43) KDM4EALDH1A1HSD17B10GAAKMT2A
SCHEMBL7423340 0.84 KMT2A (0.55) KDM4EALDH1A1HSD17B10GAAHPGD
SCHEMBL7466167 0.83 GSK3B (0.43) KDM4EALDH1A1HSD17B10GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed